Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Sale | 2025-01-02 4:47 pm | NOVAVAX INC | NVAX | King Rachel K. Director | 4,150 | $9.0205 | $37,435 | 14,770 (Direct) | View |
| 2021-05-19 Purchase | 2021-05-21 5:06 pm | NOVAVAX INC | NVAX | King Rachel K. Director | 700 | $139.64 | $97,748 | 5,000 (Indirect Direct) | View |
| 2020-12-28 Sale | 2020-12-30 4:00 pm | GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO | 84,176 | $3.91 | $329,128 | 531,206 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-12 Option Award | 2024-11-14 4:15 pm | N/A 2034-11-11 | Fulcrum Therapeutics Inc. | FULC | King Rachel K. Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:07 pm | 2025-06-12 2034-06-12 | NOVAVAX INC | NVAX | King Rachel K. Director | 15,630 | $15.86 | 44,970 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-14 4:07 pm | 2024-06-12 2033-06-12 | NOVAVAX INC | NVAX | King Rachel K. Director | 6,670 | $0 | 44,970 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:07 pm | 2025-06-12 2034-06-12 | NOVAVAX INC | NVAX | King Rachel K. Director | 10,420 | $0 | 44,970 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:27 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-03-29 Option Award | 2024-04-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 3,334 | $3 | 659,095 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 4,238 | $2.36 | 657,502 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-03 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 6,667 | $1.5 | 653,264 (Direct) | View |
| 2023-06-10 Exercise | 2023-06-13 4:46 pm | N/A N/A | NOVAVAX INC | NVAX | King Rachel K. Director | 3,100 | $0 | 26,630 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 4:46 pm | 2024-06-12 2033-06-12 | NOVAVAX INC | NVAX | King Rachel K. Director | 14,380 | $0 | 26,630 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:27 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2023-02-06 4:13 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 0 | $0 | 646,597 (Indirect) | View |
| 2022-02-15 Ownership | 2023-02-06 4:13 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 19,141 | $0 | 646,597 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-21 8:46 pm | N/A N/A | NOVAVAX INC | NVAX | King Rachel K. Director | 700 | $0 | 9,150 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 5:08 pm | 2023-06-10 2032-06-10 | NOVAVAX INC | NVAX | King Rachel K. Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:16 pm | N/A 2032-05-17 | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2021-06-25 Exercise(A) | 2021-08-20 5:29 pm | N/A N/A | NOVAVAX INC | NVAX | King Rachel K. Director | 3,450 | $0 | 9,700 (Direct) | View |
| 2021-06-25 Exercise | 2021-06-29 5:14 pm | N/A N/A | NOVAVAX INC | NVAX | King Rachel K. Director | 6,900 | $0 | 11,900 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:18 pm | 2022-06-17 2031-06-17 | NOVAVAX INC | NVAX | King Rachel K. Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2021-01-20 Option Award | 2021-01-22 4:00 pm | N/A 2031-01-19 | GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO | 288,750 | $0 | 819,956 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:00 pm | N/A 2021-01-04 | GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO | 130,821 | $0 | 531,206 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:00 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO | 130,821 | $1.12 | 531,206 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-26 9:18 pm | 2021-06-25 2030-06-25 | NOVAVAX INC | NVAX | King Rachel K. Director | 10,350 | $0 | 10,350 (Direct) | View |